Lion TCR develops personalized T cell receptor (TCR‑T) immunotherapies to eliminate Hepatitis B virus (HBV)-related hepatocellular carcinoma and to treat viral infections prevalent in Asia. The company maintains the largest patented HBV-specific TCR library covering roughly 80% of patient HLA types,...See more
Headquarters:
Singapore
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2015 (11 years)
Address:
2 TUKANG INNOVATION GROVE #09-04; SINGAPORE, 618305, SG
Employees by Department
Key Decision Makers
Insight
The company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has LION TCR been operating for?
- What is the funding status of LION TCR?
- Where is LION TCR's headquarter?
- What LION TCR's spending power?
- Does LION TCR have a presence in the domain it operates in?

